XWELL (XWEL) Tariff Resilience Score: 3/10 (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XWEL XWELL Inc XWEL
27 GF Score
Price $1.00
GF Value $0.86
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is XWELL Tariff Resilience Score?

XWELL XWEL -3.85% 27 Tariff Resilience Score is 3 as of Aug. 24, 2026. GuruFocus rates XWEL with a GF Score™ of 27/100 and a GF Value™ of $0.86 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, XWELL ranks better than 66.67% on this metric.

XWELL has the Tariff Resilience Score of 3, which implies that the company might have .

XWELL has XWELL Inc is highly dependent on international supply chains for its wellness products. The company has limited pricing power and faces significant exposure to tariffs on imports. Historical impacts from tariffs have been negative, and mitigation strategies are not robust.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes XWELL might have .

XWELL  (NAS:XWEL) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

XWELL Tariff Resilience Score Related Terms

XWEL vs MBAI, NDRA, BIAF: Tariff Resilience Score Comparison

For the Diagnostics & Research subindustry, XWELL's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XWELL Tariff Resilience Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, XWELL's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where XWELL's Tariff Resilience Score falls into.


XWEL
27GF Score
XWELL Inc XWEL
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 3 mean?
XWELL (XWEL) has a Tariff Resilience Score of 3 as of Aug. 24, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, XWELL ranks #71 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 33.3%.
Is XWELL's Tariff Resilience Score too high?
XWELL's current Tariff Resilience Score is 3. Based on the distribution chart, XWELL ranks #71 out of 213 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, XWELL has a GF Score™ of 27/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does XWELL's Tariff Resilience Score compare to MBAI and NDRA?
According to the Medical Diagnostics & Research industry distribution chart, XWELL ranks #71 out of 213 companies for Tariff Resilience Score. This puts XWELL in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Diagnostics & Research company?
A good Tariff Resilience Score depends on the Medical Diagnostics & Research industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. XWELL's current Tariff Resilience Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XWELL stock overvalued right now?
Based on GuruFocus' analysis, XWELL (XWEL) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.86, compared to a current price of $1.00 — trading 16.3% above its estimated fair value. The current Tariff Resilience Score is 3. XWELL's overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For XWELL (XWEL), the current Tariff Resilience Score is 3 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is XWELL (XWEL) Overvalued in 2026?

Based on GuruFocus' analysis, XWELL stock appears to be overvalued. The current stock price of $1.00 is trading 16.3% above its estimated GF Value™ of $0.86. GuruFocus considers XWELL to be Modestly Overvalued.

Key valuation signals for XWEL:

  • Tariff Resilience Score: 3
  • GF Value™: $0.86 vs. price of $1.00 (16.3% above fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the XWEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

XWELL Business Description

Address 254 West 31st Street, 11th Floor, New York, NY, USA, 10001
XWELL Inc is an international wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment, which generates maximum revenue, operates spa service locations in airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program. The Naples Wax Center segment operates six locations offering face and body waxing, skincare services, and cosmetic products. The Company generates maximum revenue from the United States.
27GF Score

Get the complete analysis for XWEL

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.00
Price
$0.86
GF Value